CDKN1A and gastric cancer: This would adversely affect the expression of KLF2-regulated genes such as CDKN1A and CDKN2B that encode cyclin-dependent kinase inhibitors p21 and p15, respectively, leading to augmented tumorigenesis in gastric cancers [71,72].